IGC Pharma (IGC) Asset Utilization Ratio (2011 - 2025)

IGC Pharma (IGC) has 15 years of Asset Utilization Ratio data on file, last reported at 0.13 in Q3 2025.

• Asset Utilization Ratio for Q3 2025 came in at 0.13, up 10.81% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.13 (up 10.81% YoY), and the FY2026 annual result was 0.04, down 74.06% from the prior year.
• Asset Utilization Ratio eased to 0.13 in Q3 2025 per IGC's latest filing, from 0.16 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.16 in Q2 2025 and troughed at 0.01 in Q3 2021.
• A 5-year average of 0.07 and a median of 0.08 in 2023 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2021 and 2022: Asset Utilization Ratio slumped 89.41% in 2021, then soared 277.81% in 2022.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2021, then soared by 277.81% to 0.04 in 2022, then jumped by 112.06% to 0.09 in 2023, then jumped by 45.12% to 0.13 in 2024, then decreased by 1.61% to 0.13 in 2025.
• Business Quant data shows IGC's Asset Utilization Ratio at 0.13 in Q3 2025, 0.16 in Q2 2025, and 0.14 in Q1 2025.